PMGC Holdings (ELAB) Current Leases (2022 - 2026)
PMGC Holdings' (ELAB) quarterly Current Leases came in at $647472.0 in Q2 2026, up 31.22% quarter-over-quarter from $493426.0 in Q1 2026.
Analysis
PMGC Holdings (ELAB) Current Leases (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed Current Leases across 5 years of filings, most recently posting $647472.0 for Q2 2026.
- In Q2 2026, Current Leases changed N/A year-over-year to $647472.0; the TTM figure through Jun 2026 stood at $647472.0 (changed N/A YoY), while the FY2025 annual figure was $247627.0, changed N/A from the prior year.
- Current Leases came in at $647472.0 for Q2 2026 at PMGC Holdings, up from $493426.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $140.9 million in Q3 2023 to a low of $103309.0 in Q3 2024.
- Average Current Leases over 5 years is $14.3 million, with a median of $189218.5 recorded in 2024.
- Year-over-year, Current Leases plunged 99.93% in 2024 and soared 121.89% in 2025.
- Over 5 years, Current Leases stood at $110616.0 in 2022, then jumped by 31.08% to $145000.0 in 2023, then decreased by 28.75% to $103309.0 in 2024, then jumped by 139.7% to $247627.0 in 2025, then jumped by 161.47% to $647472.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $647472.0 in Q2 2026, $493426.0 in Q1 2026, and $247627.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.40 Bn | 192.42 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.38 Bn | 177.20 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.28 Bn | 123.43 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.73 Bn | 73.73 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.28 Bn | 55.09 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 54.02 Bn | 48.88 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.28 Bn | 29.97 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.81 Bn | 30.52 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.02 Bn | 29.02 Bn | 1.16 Mn | 12.38 Mn |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 | 647,472.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 647,472.00 |
| Mar 31, 2026 | 493,426.00 |
| Dec 31, 2025 | 247,627.00 |
| Sep 30, 2025 | 229,229.00 |
| Sep 30, 2024 | 103,309.00 |
| Jun 30, 2024 | 140,063.00 |
| Mar 31, 2024 | 149,208.00 |
| Dec 31, 2023 | 145,000.00 |
| Sep 30, 2023 | 140.91 Mn |
| Dec 31, 2022 | 110,616.00 |